Effect of fibrinogen replacement therapy on bleeding outcomes and 1-year mortality in patients undergoing thoracic aortic surgery: a retrospective cohort study
- 27 November 2022
- journal article
- research article
- Published by Springer Nature in Journal of Anesthesia
- Vol. 37 (1) , 119-129
Abstract
Purpose This study aimed to examine the effect of fibrinogen replacement therapy with cryoprecipitate or fibrinogen concentrate on bleeding outcomes and 1-year mortality in patients undergoing thoracic aortic surgery. Methods We retrospectively studied 439 consecutive patients who underwent thoracic aortic surgery with cardiopulmonary bypass between January 1st, 2010 and December 31st, 2019 and identified patients who received cryoprecipitate or fibrinogen concentrate (the fibrinogen replacement group) and those who did not (the control group). Multivariate analyses were performed to examine the associations of fibrinogen replacement therapy with perioperative major bleeding (i.e., excessive hemorrhage or blood transfusion), re-exploration for bleeding, and 1-year mortality. Results There were 285 patients in the fibrinogen replacement group who received 2.2 ± 1.0 g of concentrated fibrinogen amount and 154 patients in the control group. The incidence of major bleeding in the fibrinogen replacement group was less than that in the control group in patients with fibrinogen level < 150 mg/dL during cardiopulmonary bypass (49.7% versus 74.6%, p = 0.0007, multivariate odds ratio; 0.33, 95% confidence intervals; 0.12–0.91, p = 0.03), but not in patients with fibrinogen level ≥ 150 mg/dL (25.0% versus 29.6%, p = 0.51). No significant difference was found in re-exploration for bleeding (1.0% versus 1.3%, p = 1.00) or 1-year mortality (10.4% versus 5.3%, multivariate Cox proportional-hazard ratio; 1.03, 95% confidence intervals; 0.82–1.31, p = 0.74) between the fibrinogen replacement group and the control group. Conclusions The results of this study indicate that 2–3 g of fibrinogen replacement reduces the incidence of major bleeding in patients with hypofibrinogenemia during cardiopulmonary bypass in thoracic aortic surgery.Keywords
This publication has 33 references indexed in Scilit:
- Long-term outcomes after thoracic aortic surgery: A population-based studyThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Universal definition of perioperative bleeding in adult cardiac surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapyTransfusion, 2013
- Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertainJournal of Thrombosis and Haemostasis, 2013
- Diagnostic Performance and Therapeutic Consequence of Thromboelastometry Activated by Kaolin versus a Panel of Specific ReagentsAnesthesiology, 2011
- Pathophysiology and Treatment of Coagulopathy in Massive Hemorrhage and HemodilutionAnesthesiology, 2010
- Transfusion Requirements After Cardiac SurgeryJAMA, 2010
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)Epidemiology, 2007
- Bleeding after Cardiopulmonary BypassNew England Journal of Medicine, 1986